Literature DB >> 19144572

Antibody titers predict clinical features of autoimmune autonomic ganglionopathy.

Christopher H Gibbons1, Roy Freeman.   

Abstract

Autoimmune autonomic ganglionopathy is a disorder of isolated autonomic failure associated with antibodies to the nicotinic acetylcholine receptor of the autonomic ganglia resulting in severe orthostatic intolerance, syncope, constipation, gastroparesis, urinary retention, dry mouth, dry eyes, blurred vision and anhidrosis. We report the autonomic test results, antibody titers and clinical findings in 8 patients with antibodies to the nicotinic acetylcholine receptor of the autonomic ganglia. There was a sigmoidal relation between the antibody titers and the fall in systolic blood pressure (r(2)=0.84). The threshold occurred with antibody titers of approximately 1 nmol/l. Over the linear portion of the sigmoid curve, with antibody titers in the 1-3 nmol/l range, increasing antibody titers resulted in more severe orthostatic hypotension (r=0.94, P<0.001). The saturation point of the sigmoidal relation occurred at approximately 3 nmol/l with drops in systolic blood pressure of approximately 100 mmHg during upright tilt. The antibody titers correlated inversely with the Valsalva ratio (r=-0.87, P<0.001), the 30:15 ratio (r=-0.84, P<0.001) and the expiratory to inspiratory ratio (r=-0.67, P<0.01). Patients with orthostatic intolerance, anhidrosis, constipation, urinary dysfunction, sicca syndrome and pupillary dysfunction had higher antibody titers than subjects that did not (P<0.01 in all cases). Autoimmune autonomic ganglionopathy is a clinically heterogeneous disease with variable presentation, particularly in subjects with lower antibody titers. Our data suggest that patients with higher antibody titers have wide spread dysautonomia while those with lower antibody levels may present with, or evolve into, more focal or restricted presentations.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19144572     DOI: 10.1016/j.autneu.2008.11.013

Source DB:  PubMed          Journal:  Auton Neurosci        ISSN: 1566-0702            Impact factor:   3.145


  20 in total

1.  Rituximab-based therapy and long-term control of autoimmune autonomic ganglionopathy.

Authors:  Arjun Gupta; Samar Harris; Steven Vernino; Harris V Naina
Journal:  Clin Auton Res       Date:  2015-08-07       Impact factor: 4.435

Review 2.  Acquired neuropathies.

Authors:  Pierre Lozeron; Jean-Marc Trocello; Nathalie Kubis
Journal:  J Neurol       Date:  2013-06-16       Impact factor: 4.849

Review 3.  Neurogenic lower urinary tract dysfunction: evaluation and management.

Authors:  Katarina Ivana Tudor; Ryuji Sakakibara; Jalesh N Panicker
Journal:  J Neurol       Date:  2016-07-11       Impact factor: 4.849

4.  Long-term treatment with rituximab of autoimmune autonomic ganglionopathy in a patient with lymphoma.

Authors:  Ryan Hollenbeck; Bonnie K Black; Amanda C Peltier; Italo Biaggioni; David Robertson; Elliott F Winton; Satish R Raj
Journal:  Arch Neurol       Date:  2010-11-08

Review 5.  The clinical approach to autonomic failure in neurological disorders.

Authors:  Eduardo E Benarroch
Journal:  Nat Rev Neurol       Date:  2014-05-27       Impact factor: 42.937

6.  Autoimmune autonomic neuropathies: time to look beyond autoimmune autonomic ganglionopathy.

Authors:  Srikanth Muppidi
Journal:  Clin Auton Res       Date:  2018-01-05       Impact factor: 4.435

7.  Seronegative autoimmune autonomic neuropathy: a distinct clinical entity.

Authors:  Elisabeth P Golden; Meredith A Bryarly; Steven Vernino
Journal:  Clin Auton Res       Date:  2017-12-26       Impact factor: 4.435

8.  Autoimmune autonomic ganglionopathy with reversible cognitive impairment.

Authors:  Christopher H Gibbons; Justin Centi; Steven Vernino; Roy Freeman
Journal:  Arch Neurol       Date:  2011-12-12

9.  Coexistent autoimmune autonomic ganglionopathy and myasthenia gravis associated with non-small-cell lung cancer.

Authors:  Amanda C Peltier; Bonnie K Black; Satish R Raj; Peter Donofrio; David Robertson; Italo Biaggioni
Journal:  Muscle Nerve       Date:  2010-03       Impact factor: 3.217

10.  The value of acetylcholine receptor antibody in children with postural tachycardia syndrome.

Authors:  Jiawei Li; Qingyou Zhang; Ying Liao; Chunyu Zhang; Hongjun Hao; Junbao Du
Journal:  Pediatr Cardiol       Date:  2014-08-03       Impact factor: 1.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.